Síguenos en Twitter

Síguenos en Facebook

Día Mundial de la Trombosis - 13 de Octubre

PATROCINADORES CORPORATIVOS

Noticias de la SETH

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders

The EHA Research Roadma Blood Coagulation and Hemostatic Disorders

 
Thrombotic and bleeding disorders are global disease burdens with considerable morbidity and high mortality. Estimates for the European Union (EU) suggested an annual death toll of 500,000 venous thrombosis (VT)-related deaths with a short-term mortality rate comparable to ischemic stroke. On another scale, about 1 in 300 persons is affected by an inherited bleeding disorder. Uncontrolled bleeding is a major healthcare issue not only among these patients but also among patients with an acquired bleeding disorder. Following-up on the previous addition of the EHA Roadmap, the following chapters will give you an overview and update on important developments and multidisciplinary aspects of hemostasis and thrombosis. Owing to the SARS-CoV-2 pandemic, we specifically focus on infections and coagulopathy. We will describe major needs and cutting-edge questions in basic and clinical research in this topic providing views on future developments.

VER ARTÍCULO COMPLETO

 

Compartir

Nuestra web utiliza cookies para ofrecerte un mejor servicio. Si continúas navegando, consideramos que aceptas su uso. Puedes visitar nuestro 'Uso de cookies' para obtener más información o cambiar tu configuración.